A specific deletion pattern in the preS1-and preS2-domain is associated with treatment induced HBsAg loss in chronic hepatitis B

被引：0
|
作者：
Pfefferkorn, Maria [1 ]
Deichsel, Danilo [1 ]
Matz-Soja, Madlen [1 ,2 ]
Berg, Thomas [1 ]
van Boemmel, Florian [1 ]
机构：
[1] Univ Leipzig, Med Ctr, Dept Med 2, Div Hepatol, Leipzig, Germany
[2] Univ Leipzig, Fac Med, Rudolf Schonheimer Inst Biochem, Leipzig, Germany
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-2135
引用
收藏
页码：S706 / S706
页数：1
相关论文
共 50 条
  • [21] EARLY SERUM PreS1 IS PREDICTIVE OF HBsAg LOSS IN HBEAG-POSITIVE CHRONIC HEPATITIS B CHILDREN TREATED WITH INTERFERON-ALPHA:A REAL-WORLD STUDY
    Fan, Peiyao
    Wang, Fuchuan
    Gao, Yinjie
    Zhong, Yanwei
    Xu, Zhiqiang
    Dong, Yi
    Yan, Jianguo
    Cao, Lili
    Zhang, Min, Sr.
    HEPATOLOGY, 2022, 76 : S1536 - S1537
  • [22] Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants
    Soussan, P
    Pol, S
    Garreau, F
    Bréchot, C
    Kremsdorf, D
    JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 367 - 371
  • [23] Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
    Flink, HJ
    van Zonneveld, M
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HLA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 297 - 303
  • [24] Loss Of HBsAg Following Spontaneous Versus Treatment-Induced Clearance Of HBeAg In United States Patients With Chronic Hepatitis B
    Abdalla, Adil
    Loria, Anthony
    Zhao, Xiongce
    Trenbeath, Joni
    Liang, T. Jake
    Hoofnagle, Jay H.
    Ghany, Marc G.
    HEPATOLOGY, 2013, 58 : 627A - 627A
  • [25] SERUM PRES1 ANTIGEN EXPRESSION IN A MULTICENTER CONTROLLED CLINICAL-TRIAL OF INTERFERON ALFA-2B ALONE AND IN COMBINATION WITH CORTICOSTEROID WITHDRAWAL FOR THE TREATMENT OF CHRONIC HEPATITIS-B
    PETIT, MA
    ZARSKI, JP
    CAPEL, F
    THELU, MA
    TREPO, C
    HEPATOLOGY, 1992, 16 (04) : A218 - A218
  • [26] Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a
    Minghui Li
    Lu Zhang
    Yao Lu
    Qiqi Chen
    Huihui Lu
    Fangfang Sun
    Zhan Zeng
    Gang Wan
    Linqing Zhao
    Yao Xie
    Virologica Sinica, 2021, 36 (02) : 311 - 320
  • [27] Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a
    Li, Minghui
    Zhang, Lu
    Lu, Yao
    Chen, Qiqi
    Lu, Huihui
    Sun, Fangfang
    Zeng, Zhan
    Wan, Gang
    Zhao, Linqing
    Xie, Yao
    VIROLOGICA SINICA, 2021, 36 (02) : 311 - 320
  • [28] Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B
    Guan, Guiwen
    Zhang, Ting
    Ning, Jing
    Tao, Changyu
    Gao, Na
    Zeng, Zhenzhen
    Guo, Huili
    Chen, Chia-Chen
    Yang, Jing
    Zhang, Jing
    Gu, Weilin
    Yang, Ence
    Liu, Ren
    Guo, Xiaosen
    Ren, Shan
    Wang, Lin
    Wei, Guochao
    Zheng, Sujun
    Gao, Zhiliang
    Chen, Xinyue
    Lu, Fengmin
    Chen, Xiangmei
    JOURNAL OF HEPATOLOGY, 2024, 80 (01) : 41 - 52
  • [29] On-treatment ALT flares are associated with HBsAg loss in genotype A chronic hepatitis B-infected patients treated with nucleotide analogue therapy
    Wong, D.
    Walsh, R.
    Hammond, R.
    Yuen, L.
    Revill, P.
    Gaggar, A.
    Subramanian, M.
    Kitrinos, K.
    Locarnini, S.
    Thompson, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S260 - S260
  • [30] On-treatment ALT flares are associated with HBsAG loss in genotype A chronic hepatitis B-infected patients treated with nucleotide analogue therapy
    Wong, D.
    Walsh, R.
    Hammond, R.
    Yuen, L.
    Revill, P.
    Gaggar, A.
    Subramanian, M.
    Kitrinos, K.
    Locarnini, S.
    Thompson, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 87 - 88
12345